APO Research
Talk to an analyst

APO RESEARCH · REPORT

Equine Drugs and Supplement

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Equine Drugs and Supplement Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

21 December 2025187 pages

Choose your research edition.

Industry ResearchEquine Drugs and Supplement Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Equine Drugs and Supplement Industry Growth and Trends Forecast to 203293 pages · $3,450 USDMarket StructureGlobal Equine Drugs and Supplement Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Equine Drugs and Supplement Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Equine Drugs and Supplement Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Equine Drugs and Supplement market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Equine Drugs and Supplement is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Equine Drugs and Supplement is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Equine Drugs and Supplement is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Equine Drugs and Supplement is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Equine Drugs and Supplement include Zoetis, Novartis Animal Health, Merck Animal Health, Bayer Animal Health, Merial, Elanco (Eli Lilly) and Boehringer Ingelheim, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Equine Drugs and Supplement market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Equine Drugs and Supplement and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Equine Drugs and Supplement sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Equine Drugs and Supplement market size, projected growth trends, production technologies, key applications, and end-use industries.

Equine Drugs and Supplement Segment by Company

Zoetis

Novartis Animal Health

Merck Animal Health

Bayer Animal Health

Merial

Elanco (Eli Lilly)

Boehringer Ingelheim

Equine Drugs and Supplement Segment by Type

Stable Isotope

Radioisotope

Equine Drugs and Supplement Segment by Application

Hospital

Laboratory

Others

Equine Drugs and Supplement Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Equine Drugs and Supplement market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Equine Drugs and Supplement and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Equine Drugs and Supplement.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Equine Drugs and Supplement market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Equine Drugs and Supplement manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Equine Drugs and Supplement in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Equine Drugs and Supplement in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Equine Drugs and Supplement Industry Trends Table 2. Equine Drugs and Supplement Industry Drivers Table 3. Equine Drugs and Supplement Industry Opportunities and Challenges Table 4. Equine Drugs and Supplement Industry Restraints Table 5. Global Equine Drugs and Supplement Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Equine Drugs and Supplement Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Equine Drugs and Supplement Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Equine Drugs and Supplement Sales Market Share by Manufacturers Table 9. Global Equine Drugs and Supplement Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Equine Drugs and Supplement Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Equine Drugs and Supplement Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Equine Drugs and Supplement Manufacturers, Product Type & Application Table 13. Global Equine Drugs and Supplement Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Equine Drugs and Supplement by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Stable Isotope Table 17. Major Manufacturers of Radioisotope Table 18. Global Equine Drugs and Supplement Sales by Type 2021 VS 2025 VS 2032 (k units) Table 19. Global Equine Drugs and Supplement Sales by Type (2021-2026) & (k units) Table 20. Global Equine Drugs and Supplement Sales by Type (2027-2032) & (k units) Table 21. Global Equine Drugs and Supplement Sales Market Share by Type (2021-2026) Table 22. Global Equine Drugs and Supplement Sales Market Share by Type (2027-2032) Table 23. Global Equine Drugs and Supplement Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 24. Global Equine Drugs and Supplement Revenue by Type (2021-2026) & (k units) Table 25. Global Equine Drugs and Supplement Revenue by Type (2027-2032) & (k units) Table 26. Global Equine Drugs and Supplement Revenue Market Share by Type (2021-2026) Table 27. Global Equine Drugs and Supplement Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Hospital Table 29. Major Manufacturers of Laboratory Table 30. Major Manufacturers of Others Table 31. Global Equine Drugs and Supplement Sales by Application 2021 VS 2025 VS 2032 (k units) Table 32. Global Equine Drugs and Supplement Sales by Application (2021-2026) & (k units) Table 33. Global Equine Drugs and Supplement Sales by Application (2027-2032) & (k units) Table 34. Global Equine Drugs and Supplement Sales Market Share by Application (2021-2026) Table 35. Global Equine Drugs and Supplement Sales Market Share by Application (2027-2032) Table 36. Global Equine Drugs and Supplement Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 37. Global Equine Drugs and Supplement Revenue by Application (2021-2026) & (k units) Table 38. Global Equine Drugs and Supplement Revenue by Application (2027-2032) & (k units) Table 39. Global Equine Drugs and Supplement Revenue Market Share by Application (2021-2026) Table 40. Global Equine Drugs and Supplement Revenue Market Share by Application (2027-2032) Table 41. Global Equine Drugs and Supplement Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 42. Global Equine Drugs and Supplement Sales by Region (2021-2026) & (k units) Table 43. Global Equine Drugs and Supplement Sales Market Share by Region (2021-2026) Table 44. Global Equine Drugs and Supplement Sales Forecasted by Region (2027-2032) & (k units) Table 45. Global Equine Drugs and Supplement Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Equine Drugs and Supplement Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 47. North America Equine Drugs and Supplement Sales by Country (2021-2026) & (k units) Table 48. North America Equine Drugs and Supplement Sales by Country (2027-2032) & (k units) Table 49. Europe Equine Drugs and Supplement Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 50. Europe Equine Drugs and Supplement Sales by Country (2021-2026) & (k units) Table 51. Europe Equine Drugs and Supplement Sales by Country (2027-2032) & (k units) Table 52. Asia Pacific Equine Drugs and Supplement Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 53. Asia Pacific Equine Drugs and Supplement Sales by Country (2021-2026) & (k units) Table 54. Asia Pacific Equine Drugs and Supplement Sales by Country (2027-2032) & (k units) Table 55. South America, Middle East and Africa Equine Drugs and Supplement Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 56. South America, Middle East and Africa Equine Drugs and Supplement Sales by Country (2021-2026) & (k units) Table 57. South America, Middle East and Africa Equine Drugs and Supplement Sales by Country (2027-2032) & (k units) Table 58. Global Equine Drugs and Supplement Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Equine Drugs and Supplement Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Equine Drugs and Supplement Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Equine Drugs and Supplement Revenue Market Share by Region (2021-2026) Table 62. Global Equine Drugs and Supplement Revenue Market Share by Region (2027-2032) Table 63. Zoetis Company Information Table 64. Zoetis Business Overview Table 65. Zoetis Equine Drugs and Supplement Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Zoetis Equine Drugs and Supplement Product Portfolio Table 67. Zoetis Recent Development Table 68. Novartis Animal Health Company Information Table 69. Novartis Animal Health Business Overview Table 70. Novartis Animal Health Equine Drugs and Supplement Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Novartis Animal Health Equine Drugs and Supplement Product Portfolio Table 72. Novartis Animal Health Recent Development Table 73. Merck Animal Health Company Information Table 74. Merck Animal Health Business Overview Table 75. Merck Animal Health Equine Drugs and Supplement Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Merck Animal Health Equine Drugs and Supplement Product Portfolio Table 77. Merck Animal Health Recent Development Table 78. Bayer Animal Health Company Information Table 79. Bayer Animal Health Business Overview Table 80. Bayer Animal Health Equine Drugs and Supplement Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Bayer Animal Health Equine Drugs and Supplement Product Portfolio Table 82. Bayer Animal Health Recent Development Table 83. Merial Company Information Table 84. Merial Business Overview Table 85. Merial Equine Drugs and Supplement Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Merial Equine Drugs and Supplement Product Portfolio Table 87. Merial Recent Development Table 88. Elanco (Eli Lilly) Company Information Table 89. Elanco (Eli Lilly) Business Overview Table 90. Elanco (Eli Lilly) Equine Drugs and Supplement Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Elanco (Eli Lilly) Equine Drugs and Supplement Product Portfolio Table 92. Elanco (Eli Lilly) Recent Development Table 93. Boehringer Ingelheim Company Information Table 94. Boehringer Ingelheim Business Overview Table 95. Boehringer Ingelheim Equine Drugs and Supplement Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Boehringer Ingelheim Equine Drugs and Supplement Product Portfolio Table 97. Boehringer Ingelheim Recent Development Table 98. Key Raw Materials Table 99. Raw Materials Key Suppliers Table 100. Equine Drugs and Supplement Distributors List Table 101. Equine Drugs and Supplement Customers List Table 102. Research Programs/Design for This Report Table 103. Authors List of This Report Table 104. Secondary Sources Table 105. Primary Sources List of Figures Figure 1. Equine Drugs and Supplement Product Image Figure 2. Global Equine Drugs and Supplement Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Equine Drugs and Supplement Market Size (2021-2032) & (US$ Million) Figure 4. Global Equine Drugs and Supplement Sales (2021-2032) & (k units) Figure 5. Global Equine Drugs and Supplement Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Equine Drugs and Supplement Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Stable Isotope Image Figure 9. Radioisotope Image Figure 10. Global Equine Drugs and Supplement Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 11. Global Equine Drugs and Supplement Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Equine Drugs and Supplement Sales Market Share by Type (2021-2032) Figure 13. Global Equine Drugs and Supplement Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Equine Drugs and Supplement Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Equine Drugs and Supplement Revenue Market Share by Type (2021-2032) Figure 16. Hospital Image Figure 17. Laboratory Image Figure 18. Others Image Figure 19. Global Equine Drugs and Supplement Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 20. Global Equine Drugs and Supplement Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Equine Drugs and Supplement Sales Market Share by Application (2021-2032) Figure 22. Global Equine Drugs and Supplement Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 23. Global Equine Drugs and Supplement Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Equine Drugs and Supplement Revenue Market Share by Application (2021-2032) Figure 25. North America Equine Drugs and Supplement Sales and Growth Rate (2021-2032) & (k units) Figure 26. North America Equine Drugs and Supplement Sales Market Share by Country (2021-2032) Figure 27. U.S. Equine Drugs and Supplement Sales and Growth Rate (2021-2032) & (k units) Figure 28. Canada Equine Drugs and Supplement Sales and Growth Rate (2021-2032) & (k units) Figure 29. Mexico Equine Drugs and Supplement Sales and Growth Rate (2021-2032) & (k units) Figure 30. Europe Equine Drugs and Supplement Sales and Growth Rate (2021-2032) & (k units) Figure 31. Europe Equine Drugs and Supplement Sales Market Share by Country (2021-2032) Figure 32. Germany Equine Drugs and Supplement Sales and Growth Rate (2021-2032) & (k units) Figure 33. France Equine Drugs and Supplement Sales and Growth Rate (2021-2032) & (k units) Figure 34. U.K. Equine Drugs and Supplement Sales and Growth Rate (2021-2032) & (k units) Figure 35. Italy Equine Drugs and Supplement Sales and Growth Rate (2021-2032) & (k units) Figure 36. Netherlands Equine Drugs and Supplement Sales and Growth Rate (2021-2032) & (k units) Figure 37. Asia Pacific Equine Drugs and Supplement Sales and Growth Rate (2021-2032) & (k units) Figure 38. Asia Pacific Equine Drugs and Supplement Sales Market Share by Country (2021-2032) Figure 39. China Equine Drugs and Supplement Sales and Growth Rate (2021-2032) & (k units) Figure 40. Japan Equine Drugs and Supplement Sales and Growth Rate (2021-2032) & (k units) Figure 41. South Korea Equine Drugs and Supplement Sales and Growth Rate (2021-2032) & (k units) Figure 42. Southeast Asia Equine Drugs and Supplement Sales and Growth Rate (2021-2032) & (k units) Figure 43. India Equine Drugs and Supplement Sales and Growth Rate (2021-2032) & (k units) Figure 44. Australia Equine Drugs and Supplement Sales and Growth Rate (2021-2032) & (k units) Figure 45. South America, Middle East and Africa Equine Drugs and Supplement Sales and Growth Rate (2021-2032) & (k units) Figure 46. South America, Middle East and Africa Equine Drugs and Supplement Sales Market Share by Country (2021-2032) Figure 47. Brazil Equine Drugs and Supplement Sales and Growth Rate (2021-2032) & (k units) Figure 48. South Africa Equine Drugs and Supplement Sales and Growth Rate (2021-2032) & (k units) Figure 49. Saudi Arabia Equine Drugs and Supplement Sales and Growth Rate (2021-2032) & (k units) Figure 50. Turkey Equine Drugs and Supplement Sales and Growth Rate (2021-2032) & (k units) Figure 51. Argentina Equine Drugs and Supplement Sales and Growth Rate (2021-2032) & (k units) Figure 52. UAE Equine Drugs and Supplement Sales and Growth Rate (2021-2032) & (k units) Figure 53. Egypt Equine Drugs and Supplement Sales and Growth Rate (2021-2032) & (k units) Figure 54. Chile Equine Drugs and Supplement Sales and Growth Rate (2021-2032) & (k units) Figure 55. Global Equine Drugs and Supplement Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Equine Drugs and Supplement Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Equine Drugs and Supplement Revenue (2021-2032) & (US$ Million) Figure 58. North America Equine Drugs and Supplement Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Equine Drugs and Supplement Revenue (2021-2032) & (US$ Million) Figure 60. Europe Equine Drugs and Supplement Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Equine Drugs and Supplement Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Equine Drugs and Supplement Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Equine Drugs and Supplement Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Equine Drugs and Supplement Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Equine Drugs and Supplement Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Equine Drugs and Supplement Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Stable Isotope
  • Radioisotope
Applications
  • Hospital
  • Laboratory
  • Others
Companies covered
  • Zoetis
  • Novartis Animal Health
  • Merck Animal Health
  • Bayer Animal Health
  • Merial
  • Elanco (Eli Lilly)
  • Boehringer Ingelheim

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Equine Drugs and Supplement Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Equine Drugs and Supplement Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Equine Drugs and Supplement Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Equine Drugs and Supplement Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Equine Drugs and Supplement Market Dynamics
  1. 2.1 Equine Drugs and Supplement Industry Trends
  2. 2.2 Equine Drugs and Supplement Industry Drivers
  3. 2.3 Equine Drugs and Supplement Industry Opportunities and Challenges
  4. 2.4 Equine Drugs and Supplement Industry Restraints
3 Equine Drugs and Supplement Market by Manufacturers
  1. 3.1 Global Equine Drugs and Supplement Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Equine Drugs and Supplement Sales by Manufacturers (2021-2026)
  3. 3.3 Global Equine Drugs and Supplement Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Equine Drugs and Supplement Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Equine Drugs and Supplement Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Equine Drugs and Supplement Manufacturers, Product Type & Application
  7. 3.7 Global Equine Drugs and Supplement Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Equine Drugs and Supplement Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Equine Drugs and Supplement Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Equine Drugs and Supplement Tier 1, Tier 2, and Tier 3
4 Equine Drugs and Supplement Market by Type
  1. 4.1 Equine Drugs and Supplement Type Introduction
  2. 4.1.1 Stable Isotope
  3. 4.1.2 Radioisotope
  4. 4.2 Global Equine Drugs and Supplement Sales by Type
  5. 4.2.1 Global Equine Drugs and Supplement Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Equine Drugs and Supplement Sales by Type (2021-2032)
  7. 4.2.3 Global Equine Drugs and Supplement Sales Market Share by Type (2021-2032)
  8. 4.3 Global Equine Drugs and Supplement Revenue by Type
  9. 4.3.1 Global Equine Drugs and Supplement Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Equine Drugs and Supplement Revenue by Type (2021-2032)
  11. 4.3.3 Global Equine Drugs and Supplement Revenue Market Share by Type (2021-2032)
5 Equine Drugs and Supplement Market by Application
  1. 5.1 Equine Drugs and Supplement Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Laboratory
  4. 5.1.3 Others
  5. 5.2 Global Equine Drugs and Supplement Sales by Application
  6. 5.2.1 Global Equine Drugs and Supplement Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Equine Drugs and Supplement Sales by Application (2021-2032)
  8. 5.2.3 Global Equine Drugs and Supplement Sales Market Share by Application (2021-2032)
  9. 5.3 Global Equine Drugs and Supplement Revenue by Application
  10. 5.3.1 Global Equine Drugs and Supplement Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Equine Drugs and Supplement Revenue by Application (2021-2032)
  12. 5.3.3 Global Equine Drugs and Supplement Revenue Market Share by Application (2021-2032)
6 Global Equine Drugs and Supplement Sales by Region
  1. 6.1 Global Equine Drugs and Supplement Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Equine Drugs and Supplement Sales by Region (2021-2032)
  3. 6.2.1 Global Equine Drugs and Supplement Sales by Region (2021-2026)
  4. 6.2.2 Global Equine Drugs and Supplement Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Equine Drugs and Supplement Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Equine Drugs and Supplement Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Equine Drugs and Supplement Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Equine Drugs and Supplement Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Equine Drugs and Supplement Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Equine Drugs and Supplement Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Equine Drugs and Supplement Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Equine Drugs and Supplement Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Equine Drugs and Supplement Revenue by Region
  1. 7.1 Global Equine Drugs and Supplement Revenue by Region
  2. 7.1.1 Global Equine Drugs and Supplement Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Equine Drugs and Supplement Revenue by Region (2021-2026)
  4. 7.1.3 Global Equine Drugs and Supplement Revenue by Region (2027-2032)
  5. 7.1.4 Global Equine Drugs and Supplement Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Equine Drugs and Supplement Revenue (2021-2032)
  8. 7.2.2 North America Equine Drugs and Supplement Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Equine Drugs and Supplement Revenue (2021-2032)
  11. 7.3.2 Europe Equine Drugs and Supplement Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Equine Drugs and Supplement Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Equine Drugs and Supplement Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Equine Drugs and Supplement Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Equine Drugs and Supplement Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Zoetis
  2. 8.1.1 Zoetis Company Information
  3. 8.1.2 Zoetis Business Overview
  4. 8.1.3 Zoetis Equine Drugs and Supplement Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Zoetis Equine Drugs and Supplement Product Portfolio
  6. 8.1.5 Zoetis Recent Developments
  7. 8.2 Novartis Animal Health
  8. 8.2.1 Novartis Animal Health Company Information
  9. 8.2.2 Novartis Animal Health Business Overview
  10. 8.2.3 Novartis Animal Health Equine Drugs and Supplement Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Novartis Animal Health Equine Drugs and Supplement Product Portfolio
  12. 8.2.5 Novartis Animal Health Recent Developments
  13. 8.3 Merck Animal Health
  14. 8.3.1 Merck Animal Health Company Information
  15. 8.3.2 Merck Animal Health Business Overview
  16. 8.3.3 Merck Animal Health Equine Drugs and Supplement Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Merck Animal Health Equine Drugs and Supplement Product Portfolio
  18. 8.3.5 Merck Animal Health Recent Developments
  19. 8.4 Bayer Animal Health
  20. 8.4.1 Bayer Animal Health Company Information
  21. 8.4.2 Bayer Animal Health Business Overview
  22. 8.4.3 Bayer Animal Health Equine Drugs and Supplement Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Bayer Animal Health Equine Drugs and Supplement Product Portfolio
  24. 8.4.5 Bayer Animal Health Recent Developments
  25. 8.5 Merial
  26. 8.5.1 Merial Company Information
  27. 8.5.2 Merial Business Overview
  28. 8.5.3 Merial Equine Drugs and Supplement Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Merial Equine Drugs and Supplement Product Portfolio
  30. 8.5.5 Merial Recent Developments
  31. 8.6 Elanco (Eli Lilly)
  32. 8.6.1 Elanco (Eli Lilly) Company Information
  33. 8.6.2 Elanco (Eli Lilly) Business Overview
  34. 8.6.3 Elanco (Eli Lilly) Equine Drugs and Supplement Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Elanco (Eli Lilly) Equine Drugs and Supplement Product Portfolio
  36. 8.6.5 Elanco (Eli Lilly) Recent Developments
  37. 8.7 Boehringer Ingelheim
  38. 8.7.1 Boehringer Ingelheim Company Information
  39. 8.7.2 Boehringer Ingelheim Business Overview
  40. 8.7.3 Boehringer Ingelheim Equine Drugs and Supplement Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Boehringer Ingelheim Equine Drugs and Supplement Product Portfolio
  42. 8.7.5 Boehringer Ingelheim Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Equine Drugs and Supplement Value Chain Analysis
  2. 9.1.1 Equine Drugs and Supplement Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Equine Drugs and Supplement Production Mode & Process
  6. 9.2 Equine Drugs and Supplement Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Equine Drugs and Supplement Distributors
  9. 9.2.3 Equine Drugs and Supplement Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst